{
    "clinical_study": {
        "@rank": "19942", 
        "arm_group": [
            {
                "arm_group_label": "With Bonemaster HA", 
                "description": "100 Patients using Arcos Revision Stem with BoneMaster Hydroxyapatite"
            }, 
            {
                "arm_group_label": "Without Bonemaster HA", 
                "description": "100 Arcos Hip Patients without BoneMaster Hydroxyapatite"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary purpose of this study is to evaluate the clinical performance of the Arcos\n      Revision Stem system, determine the stability of the implants, and evaluate any relationship\n      between Paprosky bone defect level and the success of the Arcos Stem."
        }, 
        "brief_title": "Arcos Revision Stem: Evaluation of Clinical Performance", 
        "completion_date": {
            "#text": "February 2021", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Complications; Arthroplasty", 
            "Osteoarthritis, Hip"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Osteoarthritis", 
                "Osteoarthritis, Hip"
            ]
        }, 
        "detailed_description": {
            "textblock": "Primary Endpoint: Harris Hip Score at 1 year follow-up Secondary Endpoints: Stability and\n      Fixation of Arcos Hip by radiographic assessment, Overall Survivorship, and Relationship\n      between Paprosky bone defect level and survivorship in years.\n\n      Case Report Forms: Demographic Data, Paprosky Acetabular/Femoral Defects, Operative Data,\n      Oxford Hip Score, Harris Hip Score, EQ-5D, Collection of X-rays, Radiographic Evaluation\n      form, Adverse Events, Revisions, Lost to Follow-up, and Protocol Deviations\n\n      200 Patients: 100 with BoneMaster HA, 100 without BoneMaster HA Up to ten sites will be used\n      to fulfill enrollment to this study\n\n      All cases enrolled will be those implanted with either the Cone, Broached, or Calcar\n      Proximal Body and one of the five distal options (Slotted, Bullet-tip, Interlocking, STS, or\n      ETO).\n\n      To be included in the study, a patient must be prescribed a revision total hip arthroplasty\n      with the Arcos system. The Arcos system is to be used in accordance to the indications for\n      use and contraindications detailed in the approved labeling of the device."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Noninflammatory degenereative joint disease including osteoarthritis and avascular\n             necrosis\n\n          -  Rheumatoid arthritis\n\n          -  Correction of functional deformity\n\n          -  Treatment of non-union, femoral neck fracture, and trochanteric fractures of the\n             proximal femur with head involvement, unmanageable using other techniques.\n\n          -  Revision of previously failed total hip arthroplasty.\n\n        The Arcos\u2122 Modular Femoral Revision System hip components are single-use implants,\n        intended for uncemented use only.\n\n        Only subjects who have received or have already been scheduled to receive hip surgery with\n        the Arcos Revision Stem System will be included in this outcomes study.\n\n        Additional Inclusion Criteria:\n\n          -  No age limit, however, the patient must have reached full skeletal maturity.\n\n          -  Willing to return for follow up evaluation.\n\n        Exclusion Criteria:\n\n        Absolute contraindications include: active infection, sepsis, and osteomyelitis.\n\n        Relative contraindications include:\n\n          -  Uncooperative patient or patient with neurologic disorders who are incapable of\n             following directions\n\n          -  Osteoporosis\n\n          -  Metabolic disorders which may impair bone formation\n\n          -  Osteomalacia\n\n          -  Distant foci of infections which may spread to the implant site\n\n          -  Rapid joint destruction, marked bone loss or bone resorption apparent on\n             roentgenogram\n\n          -  Vascular insufficiency, muscular atrophy, or neuromuscular disease."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The study population will include patients requiring a revision to a total hip\n        replacement."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820611", 
            "org_study_id": "GBMET.CR.US19"
        }, 
        "intervention": {
            "arm_group_label": [
                "With Bonemaster HA", 
                "Without Bonemaster HA"
            ], 
            "description": "Arcos Revision Stem System", 
            "intervention_name": "Arcos Revision Stem System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "March 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Fort Myers", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33907"
                    }, 
                    "name": "Joint Implant Surgeons of Florida"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40504"
                    }, 
                    "name": "Lexington Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Henderson", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89052"
                    }, 
                    "name": "Orthopaedic Institute of Henderson"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plano", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75093"
                    }, 
                    "name": "Texas Center for Joint Replacement"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Arcos Revision Stem: Evaluation of Clinical Performance", 
        "overall_official": {
            "affiliation": "Biomet, Inc.", 
            "last_name": "Russell Schenck", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Harris Hip Score", 
            "safety_issue": "No", 
            "time_frame": "1 year follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820611"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Stability and Fixation of Arcos Hip by radiographic assessment", 
                "safety_issue": "No", 
                "time_frame": "5 Year"
            }, 
            {
                "measure": "Overall Survivorship", 
                "safety_issue": "No", 
                "time_frame": "5 Year"
            }, 
            {
                "description": "Before surgery, the Paprsoky Classification will be used to determine the femoral and acetabular defect level in order to create a baseline measurement that will then be used for making comparisons and analyzing outcomes in terms of survivorship.", 
                "measure": "Relationship between bone defect level and survivorship", 
                "safety_issue": "No", 
                "time_frame": "5 Year"
            }
        ], 
        "source": "Biomet, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biomet, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}